These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25105204)

  • 21. Enhancements and limits in drug membrane transport using supersaturated solutions of poorly water soluble drugs.
    Raina SA; Zhang GGZ; Alonzo DE; Wu J; Zhu D; Catron ND; Gao Y; Taylor LS
    J Pharm Sci; 2014 Sep; 103(9):2736-2748. PubMed ID: 24382592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative Evaluation of Protein Solubility in Aqueous Solutions by PEG-Induced Liquid-Liquid Phase Separation.
    Wang Y; Latypov RF
    Methods Mol Biol; 2019; 2039():39-49. PubMed ID: 31342417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct NMR Monitoring of Phase Separation Behavior of Highly Supersaturated Nifedipine Solution Stabilized with Hypromellose Derivatives.
    Ueda K; Higashi K; Moribe K
    Mol Pharm; 2017 Jul; 14(7):2314-2322. PubMed ID: 28558250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of hydrophobic domain formation of polymeric drug precipitation inhibitors in aqueous solution.
    Zeneli E; Lange JJ; Holm R; Kuentz M
    Eur J Pharm Sci; 2024 Jul; 198():106791. PubMed ID: 38705420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PH-induced nanosegregation of ritonavir to lyotropic liquid crystal of higher solubility than crystalline polymorphs.
    Rodríguez-Spong B; Acciacca A; Fleisher D; Rodríguez-Hornedo N
    Mol Pharm; 2008; 5(6):956-67. PubMed ID: 19434919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the behavior of amorphous pharmaceutical systems during dissolution.
    Alonzo DE; Zhang GG; Zhou D; Gao Y; Taylor LS
    Pharm Res; 2010 Apr; 27(4):608-18. PubMed ID: 20151181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystallization Inhibition Properties of Cellulose Esters and Ethers for a Group of Chemically Diverse Drugs: Experimental and Computational Insight.
    Mosquera-Giraldo LI; Borca CH; Parker AS; Dong Y; Edgar KJ; Beaudoin SP; Slipchenko LV; Taylor LS
    Biomacromolecules; 2018 Dec; 19(12):4593-4606. PubMed ID: 30376299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Supersaturated polymeric micelles for oral cyclosporine A delivery.
    Yu H; Xia D; Zhu Q; Zhu C; Chen D; Gan Y
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1325-36. PubMed ID: 23954511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution.
    Chen X; Vaughn JM; Yacaman MJ; Williams RO; Johnston KP
    J Pharm Sci; 2004 Jul; 93(7):1867-78. PubMed ID: 15176074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
    Konno H; Handa T; Alonzo DE; Taylor LS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.
    Indulkar AS; Gao Y; Raina SA; Zhang GGZ; Taylor LS
    Pharm Res; 2018 Jun; 35(8):158. PubMed ID: 29916053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilizing supersaturated drug-delivery system through mechanism of nucleation and crystal growth inhibition of drugs.
    Joshi P; Sangamwar AT
    Ther Deliv; 2018 Nov; 9(12):873-885. PubMed ID: 30444454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.
    Williams HD; Anby MU; Sassene P; Kleberg K; Bakala-N'Goma JC; Calderone M; Jannin V; Igonin A; Partheil A; Marchaud D; Jule E; Vertommen J; Maio M; Blundell R; Benameur H; Carrière F; Müllertz A; Pouton CW; Porter CJ
    Mol Pharm; 2012 Nov; 9(11):3286-300. PubMed ID: 23030411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
    Trasi NS; Taylor LS
    J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cocrystal Solubility Advantage and Dose/Solubility Ratio Diagrams: A Mechanistic Approach To Selecting Additives and Controlling Dissolution-Supersaturation-Precipitation Behavior.
    Cavanagh KL; Kuminek G; Rodríguez-Hornedo N
    Mol Pharm; 2020 Nov; 17(11):4286-4301. PubMed ID: 32815731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered Hydrophobin as a Crystallization Inhibitor for Flufenamic Acid.
    Sallada N; Li Y; Berger B; Lamm MS
    ACS Appl Bio Mater; 2021 Aug; 4(8):6441-6450. PubMed ID: 35006868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conversion of a soluble diazepam prodrug to supersaturated diazepam for rapid intranasal delivery: Kinetics and stability.
    Rautiola D; Cloyd JC; Siegel RA
    J Control Release; 2018 Nov; 289():1-9. PubMed ID: 30227158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of polymers on crystal growth rate of structurally diverse compounds from aqueous solution.
    Ilevbare GA; Liu H; Edgar KJ; Taylor LS
    Mol Pharm; 2013 Jun; 10(6):2381-93. PubMed ID: 23597294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid dissolving high potency danazol powders produced by spray freezing into liquid process.
    Hu J; Johnston KP; Williams RO
    Int J Pharm; 2004 Mar; 271(1-2):145-54. PubMed ID: 15129981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cloud-point temperature and liquid-liquid phase separation of supersaturated lysozyme solution.
    Lu J; Carpenter K; Li RJ; Wang XJ; Ching CB
    Biophys Chem; 2004 Apr; 109(1):105-12. PubMed ID: 15059663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.